Short answer
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure). $150M term loan plus $30M revolver, both maturing June 2, 2032.
MARAVAI LIFESCIENCES HOLDINGS, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $150M term loan plus $30M revolver, both maturing June 2, 2032
- Refinancing funded with $98.5M cash, replacing and terminating the 2020 credit agreement
- Variable SOFR-based interest plus 5.00% margin, with 0.25% stepdown if leverage reaches 3.00x or below
- Excess-cash-flow repayments required after fiscal 2027 when first-lien net leverage exceeds 3.00x
- Debt secured by substantially all assets, with broad covenants restricting dividends, acquisitions, investments, and additional debt
Item 1.02 · Termination of a Material Definitive Agreement
- Prior Credit Agreement terminated on June 2, 2026
- All outstanding borrowings and accrued interest prepaid in full
- Debt elimination removes obligations under the prior credit facility
- Potentially reduces future interest expense and refinancing exposure
Item 7.01 · Regulation FD Disclosure
- No substantive Regulation FD disclosure provided in the excerpt
- Text is a securities-law disclaimer, not operating or financial information
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MARAVAI LIFESCIENCES HOLDINGS, INC. 8-K filings
Get the next MRVI 8-K as it lands
Follow MRVI for push alerts, or ask the research agent what this filing means.